Insider: Mazzariello Gina Chief Legal Officer - Amylyx Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 156,969 | 0 | 156,969 |
| Value | $2,161,463.13 | $0.00 | $2,161,463.13 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/13/2025 | DDS | 15,000 | Direct | COM | $8.34 | $125,046.00 | 156,969 |
| 08/12/2025 | DDS | 15,000 | Direct | COM | $8.07 | $121,102.50 | 171,969 |
| 03/31/2025 | DDS | 9,192 | Direct | COM | $3.48 | $31,954.15 | 187,969 |
| 03/03/2025 | DDS | 1,611 | Direct | COM | $3.12 | $5,022.29 | 133,310 |
| 02/24/2025 | DDS | 4,169 | Direct | COM | $3.15 | $13,144.86 | 134,921 |
| 02/03/2025 | DDS | 3,678 | Direct | COM | $3.49 | $12,839.16 | 139,090 |
| 09/30/2024 | DDS | 8,709 | Direct | COM | $3.20 | $27,840.06 | 142,768 |
| 05/15/2024 | DDS | 10,455 | Direct | COM | $1.88 | $19,654.35 | 151,477 |
| 03/05/2024 | DDS | 1,540 | Direct | COM | $18.73 | $28,840.97 | 81,372 |
| 02/23/2024 | DDS | 2,838 | Direct | COM | $18.76 | $53,230.66 | 46,245 |
| 08/15/2023 | DDS | 6,164 | Direct | COM | $20.88 | $128,686.44 | 49,083 |
| 02/24/2023 | DDS | 3,586 | Direct | COM | $34.49 | $123,671.82 | 37,414 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research